Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 18, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,376	4,269	6,481	-	-	-
Market Cap Growth	6.80%	-34.13%	-	-	-	-
Enterprise Value	4,674	2,525	4,742	-	-	-
Last Close Price	59.60	39.71	59.24	-	-	-
PE Ratio	46.58	31.85	65.48	-	-	-
Forward PE	39.73	23.69	34.44	-	-	-
PS Ratio	12.86	9.45	16.67	-	-	-
PB Ratio	2.77	1.88	2.93	-	-	-
P/TBV Ratio	2.85	1.94	2.96	-	-	-
P/FCF Ratio	-	229.29	-	-	-	-
P/OCF Ratio	55.07	33.78	73.79	-	-	-
EV/Sales Ratio	9.43	5.59	12.20	-	-	-
EV/EBITDA Ratio	34.67	20.87	51.46	-	-	-
EV/EBIT Ratio	41.18	24.58	59.86	-	-	-
EV/FCF Ratio	-1200.55	135.61	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.01	0.00
Debt / EBITDA Ratio	0.02	0.03	0.02	0.01	0.02	0.02
Debt / FCF Ratio	-	0.18	-	0.03	0.10	0.05
Asset Turnover	0.21	0.20	0.27	0.84	0.94	1.08
Inventory Turnover	2.66	2.35	2.13	2.65	3.02	3.15
Quick Ratio	26.79	25.54	27.86	1.96	2.31	2.52
Current Ratio	28.62	27.32	29.83	3.23	3.42	3.60
Return on Equity (ROE)	6.13%	5.98%	7.35%	30.27%	35.18%	18.61%
Return on Assets (ROA)	3.02%	2.77%	3.43%	16.65%	20.20%	13.69%
Return on Capital (ROIC)	3.12%	2.86%	3.67%	20.66%	25.02%	16.47%
Return on Capital Employed (ROCE)	4.90%	4.50%	3.60%	28.90%	33.50%	21.60%
Earnings Yield	2.18%	3.14%	1.53%	-	-	-
FCF Yield	-0.06%	0.44%	-0.50%	-	-	-
Dividend Yield	0.66%	0.98%	0.42%	-	-	-
Payout Ratio	28.91%	29.98%	27.28%	15.65%	0.01%	0.08%
Buyback Yield / Dilution	-9.79%	-16.87%	-14.40%	-0.16%	0.10%	-0.10%
Total Shareholder Return	-9.13%	-15.89%	-13.98%	-0.16%	0.10%	-0.10%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.